Invention Grant
- Patent Title: Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillin
-
Application No.: US17559445Application Date: 2021-12-22
-
Publication No.: US12053440B2Publication Date: 2024-08-06
- Inventor: Gene H. Zaid , Cameron E. West , Robert Preston Moore , Jason H. West
- Applicant: Ankh Life Sciences Limited
- Applicant Address: IE Dublin
- Assignee: Ankh Life Sciences Limited
- Current Assignee: Ankh Life Sciences Limited
- Current Assignee Address: IE Dublin
- Agency: Hovey Williams LLP
- Agent Crissa A. Cook
- Main IPC: A61K31/12
- IPC: A61K31/12 ; A61K31/11 ; A61K31/437 ; A61P31/14
Abstract:
The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a multiple-component antiviral formulation comprising a curcumin component, harmine component, and isovanillin component, and/or variants thereof. The formulation may also be used to inhibit SARS-CoV-2 virus in cell-based assays or in the manufacture of antiviral medicaments.
Public/Granted literature
- US20220193007A1 INHIBITION OF COVID-19 VIRUS BY MULTIPLE-COMPONENT FORMULATIONS Public/Granted day:2022-06-23
Information query
